In his study, Guido Dalbagni carries out multidisciplinary Gene and Carcinoma research. His Carcinoma study typically links adjacent topics like Genetics. His Genetics study frequently draws connections between related disciplines such as Carcinogenesis. Guido Dalbagni carries out multidisciplinary research, doing studies in Carcinogenesis and Tumor progression. Tumor progression is often connected to Cancer in his work. Cancer connects with themes related to Suppressor in his study. His study connects Internal medicine and Suppressor. His Internal medicine study frequently links to related topics such as Tumor suppressor gene. He merges Tumor suppressor gene with Gene in his study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Epidemiology and risk factors of urothelial bladder cancer
Maximilian Burger;James W.F. Catto;Guido Dalbagni;H. Barton Grossman.
European Urology (2013)
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology
Ahmad Shabsigh;Ruslan Korets;Kinjal C. Vora;Christine M. Brooks.
European Urology (2009)
Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update
M. Craig Hall;Sam S. Chang;Guido Dalbagni;Raj Som Pruthi.
The Journal of Urology (2007)
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.
Harry W. Herr;Bernard H. Bochner;Guido Dalbagni;S. Machele Donat.
The Journal of Urology (2002)
Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression
Alvaro S. Sarkis;Guido Dalbagni;Carlos Cordon-Cardo;Zuo-Feng Zhang.
Journal of the National Cancer Institute (1993)
Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.
Bernard H. Bochner;Guido Dalbagni;Michael W. Kattan;Paul Fearn.
Journal of Clinical Oncology (2006)
CYSTECTOMY FOR BLADDER CANCER: A CONTEMPORARY SERIES
Guido Dalbagni;Elizabeth Genega;Mia Hashibe;Zuo-Feng Zhang.
The Journal of Urology (2001)
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial
Bernard H. Bochner;Guido Dalbagni;Daniel D. Sjoberg;Jonathan Silberstein;Jonathan Silberstein.
European Urology (2015)
Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder Cancer
Carlos Cordon-Cardo;David Wartinger;Daniel Petrylak;Guido Dalbagni.
Journal of the National Cancer Institute (1992)
Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.
Atreya Dash;Matthew D. Galsky;Andrew J. Vickers;Angel M. Serio.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: